Skip to main content
. 2022 Dec 22;4(2):158–162. doi: 10.1016/j.jobb.2022.12.001

Table 2.

Estimation of the efficiency of the smallpox vaccine and non-pharmaceutical intervention (NPI).

Region VEs (%) VEi (%) Max. Vaccine coverage rate (%) Max. NPI (%)
USA 78.7 76.0 65.8 49.5
Europe 79.1 81.9 63.6 51.8
Global 79.1 77.7 53.5 52.0